The Effects of Serum Folic Acid and Vitamin B12 on the Risk of Gestational Diabetes Mellitus
Yao Cheng,Xinfeng Lu,Feixia Zhao,Guoqiang Sun
DOI: https://doi.org/10.2147/DMSO.S391888
2022-12-14
Abstract:Yao Cheng, 1 Xinfeng Lu, 2 Feixia Zhao, 3 Guoqiang Sun 1 1 Obstetrics Department, Maternal and Child Health Hospital of Hubei Province, Wuhan, People's Republic of China; 2 Medical Record Department, Maternal and Child Health Hospital of Hubei Province, Wuhan, People's Republic of China; 3 Medical College of Wuhan University of Science and Technology, Wuhan, People's Republic of China Correspondence: Guoqiang Sun, Obstetrics Department, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuluo Road No. 745, Hongshan District, Wuhan, 430070, People's Republic of China, Tel +86-15972153596, Email Purpose: In order to gain more knowledge on the risk of gestational diabetes mellitus (GDM), and to provide evidence for clinical guidance on the optimum level of serum folic acid and vitamin B12, this study aimed to clarify the relationship between serum folic acid and vitamin B12 and the risk of GDM. Patients and Methods: This retrospective case−control study was conducted based on the clinical information system of the Maternal and Child Health Hospital of Hubei Province. Clinical data including maternal socio-demographical characteristics, serum folic acid, and vitamin B12 were collected. Logistic regression analyses and restricted cubic splines were performed to examine the impact of serum folic acid and vitamin B12 on the risk of GDM. Results: Significantly elevated risks of GDM were observed in groups with high serum folic acid concentration (OR = 1.84, 95% CI: 1.07− 3.16), and in low vitamin B12 concentration (OR = 2.14, 95% CI: 1.26− 3.65). After stratified by age, the increased risk of GDM was still noticed in a low level of vitamin B12 among mothers aged < 30 years (OR = 4.76, 95% CI: 1.45− 15.61). In mothers with pre−pregnancy BMI < 24, elevated risk of GDM was significantly associated with a high folic acid (OR = 2.09, 95% CI: 1.11− 3.93) or a low vitamin B12 concentration (OR = 2.24, 95% CI: 1.22− 4.14). Moreover, the risk of GDM was on the decline with the increased level of folic acid in the beginning, and it started to manifest an upward trend when the serum folic acid reached 19.02 ng/mL. Conclusion: This study demonstrated that serum folic acid excess or vitamin B12 deficiency could contribute to the increased risk of GDM, and revealed the potential side effect of serum folic acid overdose. As serum folic acid and vitamin B12 tests are widely applied in clinical practice, this finding could help clinicians to evaluate maternal risk from a new perspective. Keywords: gestational diabetes mellitus, folic acid, vitamin B12, age, BMI Gestational diabetes mellitus (GDM) is a common endocrine disease during pregnancy, which is related to the elevated risk of adverse pregnancy outcomes including cesarean section, premature birth, dystocia, premature rupture of membranes, intrauterine infection, macrosomia, stillbirth, and fetal malformation. 1 GDM patients also have higher life−span risks of hyperglycemia in both mothers and their offspring. 2 The estimated prevalence of GDM was 14.0% in global, which was 12.7%, 9.2%, and 14.2% in low, middle, and high income countries, respectively. 3 Although medical health-care technology has developed rapidly in recent years, the incidence of GDM is still on the rise and it has become a global problem. 4,5 The prevention of GDM is of great significance to promote the health of mothers and their offspring worldwide. As individual modifiable factors, more and more attention has been paid to the effects of micronutrition supplements on GDM, including folic acid and vitamin B12. Folic acid and vitamin B12, classified as B−family water−soluble vitamins, are involved in one−carbon metabolism and important reactions for DNA methylation and nucleic acid, amino acid, and lipid metabolism. 6 It is well established that dietary and supplemental intakes of folic acid are recommended for the prevention of neural tube defects. According to the latest clinical practice guideline by the Society of Obstetricians and Gynaecologists of Canada (SOGC), women with no history of neural tube defect were recommended to take 400μg or 1000μg folic acid supplement per day, 7 while it was 400μg or 800μg recommended by the US Preventive Services Task Force (USPSTF). 8 Additionally, total folic acid intake during pregnancy should reach 600μg dietary folic acid equivalent per day including 400μg folic acid supplements, which is suggested by the Chinese Nutrition Society. 9 Folic acid and vitamin B12 closely interacted, and either of their deficiencies could lead to hyperhomocysteinemia and -Abstract Truncated-